Jpmorgan Chase & Co »

Cyclo Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Cyclo Therapeutics (CYTH) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Cyclo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyclo Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclo Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $28 18 1.61
2023-09-30 $342 240 1.43

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Cyclo Therapeutics

Founders Fund V Management
Vanguard Group
Founders Fund VI Management
Citadel Advisors
Wealth Enhancement Advisory Services
Princeton Global Asset Management
Wells Fargo & Company
Royal Bank of Canada
Advisor Group Holdings
New York State Common Retirement Fund
Steward Partners Investment Advisory
Jpmorgan Chase & Co
Bank of America Corporation

View all funds holding Cyclo Therapeutics